- UK granted emergency use authorization for Pfizer and BioNTech COVID-19 vaccine
- Disappointing ADP payrolls report
- US crude inventories fall less than expected
Major bourses in Europe finished today's session in mixed moods with the DAX 30, CAC 40 and FTSE MIB falling into negative territory and the FTSE 100 and IBEX 35 outperforming regional peers. Uncertainty regarding post-Brexit trade deal negotiations overshadowed positive news about coronavirus vaccines. Also, better-than-expected German retail trade data for October did not managed to lift market sentiment. With only 29 days to go until the end of the transition period, trade talks remain stalled as disagreements over fishing, state aid, and dispute resolution remain. Chief EU Brexit negotiator Michel Barnier warned today he can not guarantee he will strike a trade deal with Britain before the end of the year. "Intensive negotiations are continuing in London, but as of this morning it is still unclear whether negotiators can bridge the gaps on issues like level playing field, governance and fisheries," Barnier said. Meanwhile British officials authorized Pfizer (PFE.US) and Germany's BioNTech (BNTX.US) COVID-19 vaccine for emergency use. Government said that vaccine would be rolled out from next week.
US stocks are swinging between small gains and losses as investors weighed the first approval of a coronavirus vaccine and the prospects of more US economic stimulus with weak ADP report. Hopes that a new coronavirus-aid bill could be unveiled soon faded after Senate Majority Leader Mitch McConnell rejected a bipartisan proposal for a $908 billion stimulus package aimed at breaking the stalemate over new stimulus in Congress. President-elect Joe Biden said in an interview with the New York Times that getting a generous stimulus package through Congress is a top priority. He also said he would not immediately cancel the Phase 1 trade deal that President Donald Trump struck with China. Meanwhile disappointing ADP report indicate that ever-increasing number of new infections and business restrictions were hampering the labor market's recovery.
US crude futures are trading nearly 3% higher at $45.86 a barrel, while the international benchmark Brent contract rose 2.75% to $48.73. US crude inventories fell by 0.679k barrels in the latest week, while analysts expected a 2.358 million drop, according to EIA report. Today's data contradicts yesterday's API report which showed 4.1 million barrels increase. Meantime, investors are waiting for OPEC+ decision on whether to delay January’s planned output increase. Elsewhere, gold futures rose 0.6% to $1,826.00/oz, while silver fell 0.4% to $23.90. EUR/USD is trading 0.2% higher at 1.2095 amid weaker dollar.
GBPUSD – pair bounced off the major support at 1.3310 and is testing 50 SMA (green line). In case buyers manage to break above it, the next resistance level to watch can be found at 1.3397. However if sellers will manage to break below the aforementioned support level, then another downward impulse towards 1.3196 level could be launched. Source: xStation5
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
